Subsequent Risks of Parkinson Disease in Patients with Autoimmune and Related Disorders: A Nationwide Epidemiological Study from Sweden

被引:82
作者
Li, Xinjun [1 ]
Sundquist, Jan [2 ]
Sundquist, Kristina
机构
[1] Lund Univ, Ctr Primary Hlth Care Res, CRC, SUS, SE-20502 Malmo, Sweden
[2] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
关键词
Autoimmune disorders; Subsequent Parkinson disease; Population-based study; Follow-up study; ANKYLOSING-SPONDYLITIS; HOSPITALIZATION; SCLEROSIS;
D O I
10.1159/000333222
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To investigate associations between autoimmune disorders and Parkinson disease (PD), and to study whether the risk is associated with follow-up time and age. Methods: Standardized incidence ratios (SIRs) were calculated for PD in patients with autoimmune disorders by comparing them to subjects without autoimmune disorders. Results: Among 310,522 patients with a total of 33 conditions of autoimmune disorders, 932 patients developed subsequent PD, giving an overall SIR of 1.33 and 1.19 for PD diagnosed later than 1 year after follow-up. Six types of autoimmune disorders showed an increased risk. These conditions included: amyotrophic lateral sclerosis, Graves's disease/hyperthyroidism, Hashimoto's disease/hypothyroidism, multiple sclerosis, pernicious anemia, and polymyalgia rheumatica. The risks depended on the age at hospitalization for PD. Conclusions: A 33% overall excess risk of PD was noted among patients with an autoimmune disorder; the risk was increased during the first 10 years of follow-up after hospitalization of autoimmune disorders. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:277 / 284
页数:8
相关论文
共 20 条
[1]   Epidemiology of ankylosing spondylitis in Northwest Greece, 1983-2002 [J].
Alamanos, Y ;
Papadopoulos, NG ;
Voulgari, PV ;
Karakatsanis, A ;
Siozos, C ;
Drosos, AA .
RHEUMATOLOGY, 2004, 43 (05) :615-618
[2]  
Andrés E, 2007, J FAM PRACTICE, V56, P537
[3]  
[Anonymous], 2009, Modern epidemiology
[4]   Risk of haematopoietic cancer in patients with inflammatory bowel disease [J].
Askling, J ;
Brandt, L ;
Lapidus, A ;
Karlén, P ;
Björkholm, M ;
Löfberg, R ;
Ekbom, A .
GUT, 2005, 54 (05) :617-622
[5]   Incidence and prevalence of ankylosing spondylitis in Northern Norway [J].
Bakland, G ;
Nossent, HC ;
Gran, JT .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (06) :850-855
[6]   Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases [J].
Dhib-Jalbut, Suhayl ;
Arnold, Douglas L. ;
Cleveland, Don W. ;
Fisher, Mark ;
Friedlander, Robert M. ;
Mouradian, M. Maral ;
Przedborski, Serge ;
Trapp, Bruce D. ;
Wyss-Coray, Tony ;
Yong, V. Wee .
JOURNAL OF NEUROIMMUNOLOGY, 2006, 176 (1-2) :198-215
[7]   Steroid-reversible parkinsonism as presentation of polymyalgia rheumatica [J].
Fietta, Pieranna ;
Manganelli, Paolo .
CLINICAL RHEUMATOLOGY, 2006, 25 (04) :564-565
[8]   Parkinson's - Divergent causes, convergent mechanisms [J].
Greenamyre, JT ;
Hastings, TG .
SCIENCE, 2004, 304 (5674) :1120-1122
[9]   Hyperthyroidism exaggerating parkinsonian tremor: A clinical lesson [J].
Kim, HT ;
Edwards, MJ ;
Narsimhan, RL ;
Bhatia, KP .
PARKINSONISM & RELATED DISORDERS, 2005, 11 (05) :331-332
[10]   Parkinson's disease - First of two parts [J].
Lang, AE ;
Lozano, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (15) :1044-1053